2020 American Transplant Congress
Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3
Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX
*Purpose: Current dosing recommendations for the administration of basiliximab on post-operative days (POD) 0 and 4 stem from two phase 3 renal transplant studies. Limited…2020 American Transplant Congress
Kidney Transplant from Sickle Cell Donors
University of Mississippi, Jackson, MS
*Purpose: Patients with End-stage renal disease have an increased risk of death. Dialysis and kidney transplantation are the only treatments. Patients who receive kidney transplantation…2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
1UCSF, San Francisco, CA, 2UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…2020 American Transplant Congress
De Novo DSA in the Setting of Stable Renal Allograft Function Does Not Impair Long-Term Graft Survival
*Purpose: To determine the long-term outcome of renal allograft recipients with de novo DSA (dnDSA) in the setting of stable allograft function.*Methods: A single-center review…2020 American Transplant Congress
Anatomy of a Conversation: Assessing ESRD Patients’ Transplant-Related Communication
Social and Behavioral Sciences, Temple University, Philadelphia, PA
*Purpose: Live Donor and Deceased Donor Kidney Transplantation (LDKT and DDKT) confer meaningful survival, and quality of life benefits to patients with End Stage Renal…2020 American Transplant Congress
Operative vs. Non-Operative Management of Hemorrhage in the Postoperative Kidney Transplant Patient
*Purpose: Postoperative hemorrhage has been described at rates of 14 percent in kidney transplant (KT) literature. The preferred management of postoperative hemorrhage in this population…2020 American Transplant Congress
CMV, EBV and BKV Viremia Rate Varied Depending on the Timing of Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression and HLA-Sensitization (HS) Status in Kidney Transplant Patients (KTx Pts)
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Viral infections (VI) represent significant morbidity and mortality factors for KTx Pts. We previously showed more VI in BLT-treated Pts compared with CNI Pts…2020 American Transplant Congress
The Application of Electron Microscope Examination in Evaluation of Donor Liver Quality in Liver Transplantation
*Purpose: Liver transplantation (LT) is considered as the only curable treatment for patients with end stage liver diseases. Post-operative complications include early allograft dysfunction (EAD),…2020 American Transplant Congress
The Liver Outcome Monitoring Registry Consortium: Data and Preliminary Outcome Results
*Purpose: The Liver Outcome Monitoring Registry (LOMR) is an online platform for collecting and monitoring liver outcome data of marginal and DCD organs to be…2020 American Transplant Congress
Liver Transplantation for Pediatric Genetic and Metabolic Liver Disease: A Single-Center Experience
*Purpose: Pediatric liver transplantation (LT) is an established treatment for a myriad of liver diseases most notably biliary atresia and urea cycle defects. In the…
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 223
- Next Page »